Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 May 13;29(10):1929–1939. doi: 10.1158/1055-9965.EPI-19-1363

Table 4.

Fine particulate matter (PM2.5) and mortality among adolescent and young adult cancer carcinoma patients

PM2.5 per 5 ug/m3 PM2.5 ≥12 ug/m3

5 years post-diagnosis 10 years post-diagnosis 5 years post-diagnosis 10 years post-diagnosis
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Cancer mortality
Breast 1.18 0.91–1.54 1.16 0.97–1.39 1.50a 1.29–1.74 1.30a 1.13–1.50
Cervical 0.84 0.62–1.13 0.83 0.67–1.02 0.83 0.61–1.13 0.78 0.57–1.06
Colorectal 1.36a 1.06–1.75 1.23a 1.00–1.52 1.74a 1.29–2.35 1.67a 1.20–2.31
Kidney and renal pelvis 4.06a 2.06–7.99b 6.95a 3.10–15.59b -- --
Lung 0.94 0.68–1.29 0.86 0.59–1.26 -- --
Testicular 0.92 0.54–1.58b 0.88 0.54–1.42b -- --
Thyroid -- 1.16 0.61–2.19b -- --
Other 1.09 0.98–1.22 1.05 0.94–1.19 1.03 0.88–1.20 1.00 0.84–1.18
All-cause mortality
Breast 1.26 0.98–1.62 1.20 0.99–1.45 1.62a 1.42–1.84 1.36a 1.19–1.55
Cervical 0.86 0.74–1.01 0.83a 0.76–0.90 0.85 0.62–1.18 0.73a 0.54–0.99
Colorectal 1.31a 1.04–1.66 1.21 0.99–1.49 1.65a 1.35–2.03 1.64a 1.31–2.04
Kidney and renal pelvis 2.86a 2.09–3.91 2.09a 1.16–3.79b -- --
Lung 1.02 0.77–1.34 0.93 0.67–1.29 -- --
Testicular 0.99 0.58–1.70b 0.95 0.62–1.46 -- --
Thyroid -- 1.28 0.74–2.23b -- --
Other 1.07 0.98–1.18 1.04 0.94–1.15 1.01 0.84–1.21 0.99 0.82–1.19

HR=hazard ratio; 95% CI=95% confidence interval; Cumulative average monthly PM2.5 over all residential ZIP codes over 5 and 10 years; Models adjusted for sex, race/ethnicity, age at diagnosis, and census tract SES at diagnosis clustered by county; Separate baseline hazard included for stage of diagnosis; Estimates rounded to the nearest hundredth;

a

Hazard ratios significant if null value not included in the 95% CI;

b

Ratio of upper-to-lower 95% confidence interval is ≥3;

--

Event count <10.